Heparin Product Offering Now Among Broadest Available LAKE FOREST, Ill., Aug. 31 (HSMN NewsFeed) — Hospira, Inc. (NYSE: HSP ), the world leader in generic injectable pharmaceuticals, today announced that the U.S. Food and Drug Administration (FDA) ha…
Biopharmaceuticals, FDA
Hospira, heparin, anticoagulant

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Hospira Receives FDA Approval for Six New Presentations of Heparin”
Leave a Comment